Cours High Hampton Holdings Corp Canadian Securities Exchange
Actions
CA42966X3094
Produits pharmaceutiques
CA 2022 | - | CA 2023 | - | Capitalisation | 563 k 413 k 376 k |
---|---|---|---|---|---|
Résultat net 2022 | - 0 0 | Résultat net 2023 | - 0 0 | VE / CA 2022 | - |
Trésorerie nette 2022 | 841 k 617 k 562 k | Trésorerie nette 2023 | 690 k 506 k 461 k | VE / CA 2023 | - |
PER 2022 |
22,9
x | PER 2023 |
-8,18
x | Employés | - |
Rendement 2022 * |
-
| Rendement 2023 |
-
| Flottant | 79,53% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Robert Dubeau
CEO | Chief Executive Officer | - | 26/09/23 |
Director of Finance/CFO | 54 | 19/09/23 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director of Finance/CFO | 54 | 19/09/23 | |
Robert Dubeau
CEO | Chief Executive Officer | - | 26/09/23 |
Anderson Shannon
BRD | Director/Board Member | - | 19/09/23 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |